1 big new Green Flag for CRISPR Therapeutics' Stock [Yahoo! Finance]
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $86.00 price target on the stock.
Capsida Biotherapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Celebrating a Milestone: Engineering Tomorrow Reaches 1 Million Students [Yahoo! Finance]
2 Growth Stocks That Could Rocket Higher in 2025: Are They Right for Your Portfolio? [Yahoo! Finance]